Summary
Eli Lilly and Company (LLY) filed an 8-K on February 6, 2024, to report its financial results for the quarter and year ended December 31, 2023. The filing incorporates by reference a press release, dated February 6, 2024, containing these results. While the 8-K itself does not detail the financial figures, it serves as the official notification mechanism for the release of this information to the public and investors. Investors should refer to the accompanying press release (Exhibit 99.1) for specific financial performance data, including revenue, earnings, and guidance for the upcoming periods.
Key Highlights
- 1Eli Lilly and Company (LLY) filed an 8-K on February 6, 2024, to announce its financial results for Q4 and full-year 2023.
- 2The filing incorporates by reference a press release dated February 6, 2024, which contains the detailed financial results.
- 3This 8-K filing serves as the official notice of the financial results announcement.
- 4Investors are directed to the press release (Exhibit 99.1) for specific financial performance metrics and commentary.
- 5The report is for the period ending December 31, 2023.